DE69002927T2 - Halbsynthetische Derivate mit immunomodulierender Wirkung, geeignet für parenterale oder orale Verabreichung. - Google Patents

Halbsynthetische Derivate mit immunomodulierender Wirkung, geeignet für parenterale oder orale Verabreichung.

Info

Publication number
DE69002927T2
DE69002927T2 DE90123092T DE69002927T DE69002927T2 DE 69002927 T2 DE69002927 T2 DE 69002927T2 DE 90123092 T DE90123092 T DE 90123092T DE 69002927 T DE69002927 T DE 69002927T DE 69002927 T2 DE69002927 T2 DE 69002927T2
Authority
DE
Germany
Prior art keywords
fraction
acids
semi
synthetic derivatives
conjugation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90123092T
Other languages
German (de)
English (en)
Other versions
DE69002927D1 (de
Inventor
Fabio Borella
Ivo Volpato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDIOM LAB
Original Assignee
MEDIOM LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDIOM LAB filed Critical MEDIOM LAB
Application granted granted Critical
Publication of DE69002927D1 publication Critical patent/DE69002927D1/de
Publication of DE69002927T2 publication Critical patent/DE69002927T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Specific Conveyance Elements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Attitude Control For Articles On Conveyors (AREA)
  • Packaging Frangible Articles (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Intermediate Stations On Conveyors (AREA)
DE90123092T 1989-12-14 1990-12-03 Halbsynthetische Derivate mit immunomodulierender Wirkung, geeignet für parenterale oder orale Verabreichung. Expired - Fee Related DE69002927T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22693A IT1237903B (it) 1989-12-14 1989-12-14 Derivati semisintetici ad attivita' immunomodulante atti alla somminitrazione parenterale ed orale

Publications (2)

Publication Number Publication Date
DE69002927D1 DE69002927D1 (de) 1993-09-30
DE69002927T2 true DE69002927T2 (de) 1994-02-03

Family

ID=11199317

Family Applications (2)

Application Number Title Priority Date Filing Date
DE90123092T Expired - Fee Related DE69002927T2 (de) 1989-12-14 1990-12-03 Halbsynthetische Derivate mit immunomodulierender Wirkung, geeignet für parenterale oder orale Verabreichung.
DE90917663T Expired - Fee Related DE69003239T2 (de) 1989-12-14 1990-12-05 Orientierungs- und verpackungsvorrichtung für ampullen, insbesondere für ampullen für injektionsspritzen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE90917663T Expired - Fee Related DE69003239T2 (de) 1989-12-14 1990-12-05 Orientierungs- und verpackungsvorrichtung für ampullen, insbesondere für ampullen für injektionsspritzen.

Country Status (12)

Country Link
US (1) US5157894A (enExample)
EP (1) EP0433744B1 (enExample)
JP (2) JPH0786009B2 (enExample)
KR (1) KR910011273A (enExample)
AT (2) ATE93391T1 (enExample)
AU (2) AU6872291A (enExample)
CA (1) CA2031394A1 (enExample)
DE (2) DE69002927T2 (enExample)
DK (1) DK0460134T3 (enExample)
ES (2) ES2058737T3 (enExample)
IT (1) IT1237903B (enExample)
PT (1) PT96207A (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654392B2 (en) * 1991-09-23 1994-11-03 Csl Limited Enzymatically-inactive phospholipase D of corynebacterium pseudotuberculosis
DE69312964T2 (de) * 1992-12-18 1997-12-11 Procter & Gamble Verfahren und vorrichtung zum fördern,gruppieren und ausrichten von gegenständen
USD366053S (en) 1993-06-26 1996-01-09 Gizeh-Werk Gmbh Machine for filling cigarette tubes
WO1995020650A1 (en) * 1994-01-28 1995-08-03 Irina Pavlovna Smirnova Strain of trichoderma harzianum rifai, process for obtaining l-lysine-alpha-oxidase as an inhibitor of viral and bacterial activity, immunomodulator and skin healing agent
US5746042A (en) * 1996-04-02 1998-05-05 Scientific Resources, Inc. Vial capping device
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
RU2127119C1 (ru) * 1997-12-08 1999-03-10 Андреева Зоя Михайловна Способ получения неспецифического инактивированного жидкого иммуномодулятора из коринебактерий (модкор)
US7392638B2 (en) * 2000-08-10 2008-07-01 Baxa Corporation Method, system, and apparatus for handling, labeling, filling, and capping syringes with improved cap
AU2001290528A1 (en) * 2000-08-10 2002-02-18 Baxa Corporation Method, system, and apparatus for handling, labeling, filling, and capping syringes
US6915619B2 (en) 2001-08-10 2005-07-12 Baxa Corporation Method for handling syringe bodies
JP4593981B2 (ja) * 2004-06-14 2010-12-08 株式会社フジシールインターナショナル 容器供給装置
EP1669096A1 (en) * 2004-12-08 2006-06-14 Moller & Devicon A/S Method, tray and apparatus for handling syringes
DE102005042380A1 (de) * 2005-09-06 2007-03-08 Nordson Corporation, Westlake Vorrichtung und Verfahren zum Erzeugen eines Schaummaterials
EP2345581B1 (en) * 2010-01-15 2015-03-11 Graphic Packaging International, Inc. Large container loading system and method for a packaging machine
ITFI20110140A1 (it) * 2011-07-18 2013-01-19 In Fieri S R L Composizione ad uso topico per il trattamento delle alopecie
ITMI20121597A1 (it) * 2012-09-25 2014-03-26 Beta Pharma S A Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
CN109959874B (zh) * 2019-03-21 2021-03-05 南京工程学院 一种电动汽车电芯测试装置
CN110002038A (zh) * 2019-05-01 2019-07-12 瑞安市海诚机械有限公司 一种全自动注射器包装机

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3027699A (en) * 1959-06-10 1962-04-03 Nat Dairy Prod Corp Packaging apparatus
US3133393A (en) * 1961-09-05 1964-05-19 R A Jones And Company Inc Article timing and transfer mechanism for cartoning machines
FR1320769A (fr) * 1962-01-04 1963-03-15 Wellcome Found Procédé de préparation de toxoïdes améliorés
ES422692A1 (es) * 1974-01-23 1976-04-01 Marquez Serra Maquina para la colocacion de ampollas de inyectables, via-les y envases similares en los correspondientes soportes.
FR2269961B1 (enExample) * 1974-05-06 1978-03-24 Anvar
FR2427257A1 (fr) * 1978-05-29 1979-12-28 Expandet Sa Machine distributrice pour la mise en place d'objets stockes sur des grilles presentoirs
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4353456A (en) * 1979-04-27 1982-10-12 Nippon Elanco Kabushiki Kaisha Capsule orientation control method and apparatus
DE3011398A1 (de) * 1980-03-25 1981-10-01 Robert Bosch Gmbh, 7000 Stuttgart Verfahren und vorrichtung zum vereinzeln und uebergeben von gegenstaenden, vorzugsweise gluehlampen
US4509309A (en) * 1983-08-08 1985-04-09 H. J. Langen & Sons Limited Load orienting receptacles for carton loading machines
FR2561523B1 (fr) * 1984-03-23 1986-07-11 Pasteur Institut Nouvelles preparations d'allergenes, leur procede d'obtention et leur application en tant qu'agents de desensibilisation
CH663185A5 (de) * 1984-05-09 1987-11-30 Sig Schweiz Industrieges Vorrichtung zum selbsttaetigen einfuellen von gestapelten, scheibenfoermigen gegenstaenden in einseitig offene verpackungsbehaelter.
JPS61164106A (ja) * 1985-01-16 1986-07-24 Murata Mfg Co Ltd 表示不良の自動識別方法
JPS61295976A (ja) * 1985-06-24 1986-12-26 Murao Boki Kk ボビンの垂直搬送用コンベア
FR2624094B1 (fr) * 1987-12-07 1990-04-13 Rhone Poulenc Sante Propharm Distributeur de seringues dans une encartonneuse a godets
US4982556A (en) * 1989-05-09 1991-01-08 Tisma Machine Corporation Modularly constructed automatic packaging machine

Also Published As

Publication number Publication date
IT8922693A0 (it) 1989-12-14
AU6808990A (en) 1991-06-20
DE69003239T2 (de) 1994-01-05
CA2031394A1 (en) 1991-06-15
JPH0786009B1 (enExample) 1995-09-20
ES2044619T3 (es) 1994-01-01
ATE93391T1 (de) 1993-09-15
US5157894A (en) 1992-10-27
DE69003239D1 (de) 1993-10-14
IT8922693A1 (it) 1991-06-14
JPH0786009B2 (ja) 1995-09-20
DK0460134T3 (da) 1993-12-27
AU6872291A (en) 1991-05-31
ATE94132T1 (de) 1993-09-15
EP0433744A1 (en) 1991-06-26
ES2058737T3 (es) 1994-11-01
EP0433744B1 (en) 1993-08-25
IT1237903B (it) 1993-06-18
PT96207A (pt) 1991-09-30
DE69002927D1 (de) 1993-09-30
JPH06184197A (ja) 1994-07-05
AU643959B2 (en) 1993-12-02
KR910011273A (ko) 1991-08-07

Similar Documents

Publication Publication Date Title
DE69002927T2 (de) Halbsynthetische Derivate mit immunomodulierender Wirkung, geeignet für parenterale oder orale Verabreichung.
DE68923723T2 (de) Modifizierter humaner G-CSF.
DE2450355A1 (de) Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe
EP0151246A2 (de) Neue Polypeptide mit alpha-Amylase-hemmender Wirkung, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE3434766A1 (de) Einen pyridinloeslichen extrakt und gereinigtes entgiftetes endotoxin enthaltendes pharmazeutisches praeparat
DE3448149C2 (enExample)
DE69420872T2 (de) Hgh enthaltende pharmazeutische zubereitungen
DE2813353A1 (de) Substanz ks-2-a, verfahren zu deren herstellung und diese substanz enthaltendes mittel
DE69116321T2 (de) Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält
DE2922533A1 (de) Oligomere von muramylpeptidartigen verbindungen und sie enthaltende arzneimittel
DE69315388T2 (de) Aus bakteriellen Proteinen bestehender Extrakt, Verfahren zur dessen Herstellung und diesen Extrakt enthaltende pharmazeutische Zusammensetzung
DE4139639A1 (de) Waessrige synthetische organextrakte
DE3787887T2 (de) Verfahren zum Züchten von Bordetella-Pertussis, ein Pertussis-Toxoid und ein Pertussis-Impfstoff.
DD202168A5 (de) Verfahren zur herstellung eines glycoproteins
US4952399A (en) Pharmaceutical composition which inhibits the growth of a tumor
DE69112573T2 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
DE3881198T2 (de) Antiviraler wirkstoff.
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
EP0338308A2 (de) Substituierte N-Glycosylamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2710455C2 (de) N-Acetylmuramyl-L-alanyl-D-glutaminsäure-alpha-methylamid, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE3884672T2 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
CH639667A5 (de) Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen.
DE68908958T2 (de) Peptide.
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
DE3685744T2 (de) Fraktion von listeria monocytogenes mit therapeutischer wirkung, verfahren fuer ihre herstellung und diese enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee